Dublin, Nov. 26, 2018 (GLOBE NEWSWIRE) — The “Global Wearable Injectors Market by Type, by Technology, by Application, by End-user, by Size and Forecast, 2012-2024” report has been added to ResearchAndMarkets.com’s offering.
Global Wearable Injectors market report provides analysis for the period 2012-2024. The market study reveals that the Global Wearable Injectors market is projected to rise over a CAGR of 24.53% during 2018-2024 in terms of value.
This growth is driven by rising usage of advance drug delivery devices at home. Rise in prevalence of chronic diseases among old age population is surging the demand for wearable injector’s products over the projected time frame.
On the basis of the type of product, body-worn patch injector devices hold 46.92% market share of global wearable injectors market. Off-Body Worn Belt Injector and Bolus Injector type devices will grow with a CAGR of 5.78% and 42.36% in term of value, respectively. North America is leading the global wearable injectors market with a CAGR of 24.48%, in terms of value. Electronic injectors is likely to surpass USD 7,861.5 million by 2024 owing shift in usage of self-administrative injectable devices and availability at economic prices.
Major Findings
- The demand for Global Wearable Injectors market is expected to grow at a significant rate, during forecast period. Wearable Injectors is witnessing tremendous growth owing to increasing life expectancy and fall in birth rates increasing old age population. The elderly population requires extensive care, as they are prone to illness due to low immunity levels and high recovery time. The elderly people are more susceptible to chronic diseases, such as cancer, diabetes, neurological disorders and cardiovascular diseases, thus increasing the usage of wearable injectors across the globe.
- Body-worn patch injectors are the largest contributor, in terms of value, as compared to Off-body worn belt injectors. It is expected to rise with CAGR over 5.8% by value during the forecast period, 2012-2024.
- Global Wearable Injectors market for technology segment is estimated to rise with a CAGR over 20.69% during the period of 2018-2024 with electronic injectors being the highest revenue generator, with market share of 54.76%.
- North America is the fastest growing region in the Wearable Injectors market and is expected to propel with a CAGR over 24.48% by value during the forecast period, 2018-2024 with Japan being the fastest growing market having a CAGR over 21.9% and expected to reach revenue of around USD 1,170.4 million by the end of 2024.
Key Topics Covered
1. Research Methodology
1.1 Market Definition
1.2 Research Scope
1.2.1 Global wearable injector market, by type
1.2.2 Global wearable injector market, by technology
1.2.3 Global wearable injector market, by application
1.2.4 Global wearable injector market, by end user
1.2.5 Global wearable injector market, by geography
1.3 Research Approach and Sources
2. Executive Summary
2.1 Key Findings
2.2 Research Summary
3. Market Outlook
3.1 Introduction
3.2 Global Wearable Injectors Market Opportunities
3.2.1 High usage of wearable injectors in emerging markets
3.3 Factors Driving the Growth of the Market and its Impact on Market Forecast
3.3.1 Global ageing population
3.3.2 Accelerating pervasiveness of chronic diseases
3.3.3 Growing demand for advance drug delivery
3.3.4 Rise in pipeline for biologic drugs
3.3.5 Market analysis of drivers over forecast period
3.4 Restraining Factors hindering market growth
3.4.1 Alternative drug delivery methods
3.4.2 Disadvantage of wearable injector
3.4.3 Market challenges analysis on market forecast
4. Global Wearable Injectors Market Size and Forecast (2012 – 2024)
4.1 Global Wearable Injectors Market, by Type
4.2 Global Wearable Injectors Market, by Technology
4.3 Global Wearable Injectors Market, by Application
4.4 Global Wearable Injectors Market, by End User
4.5 Global Wearable Injectors Market, by Region
5. Global Wearable Injectors Market, by Type
5.1 Body-Worn Patch Injector Market
5.1.1 Global body-worn patch injector market, by region
5.2 Off-Body Worn Belt Injector Market
5.2.1 Global off-body worn belt injector market, by region
5.3 Bolus Injector Market
5.3.1 Global bolus injector market, by region
6. Global Wearable Injectors Market, by Technology
6.1 Electronic Wearable Injector Market
6.1.1 Global electronic wearable injector market, by region
6.2 Mechanical Wearable Injector Market
6.2.1 Global mechanical wearable injectors market, by region
7. Global Wearable Injectors Market, by Application
7.1 Wearable Injector Market for Cancer
7.1.1 Global wearable injector market for cancer, by region
7.2 Wearable Injector Market for Infectious Disease
7.2.1 Global wearable injector market for infectious disease, by region
7.3 Wearable Injector Market for Autoimmune Disorder
7.3.1 Global wearable injectors for autoimmune disorder, by region
7.4 Wearable Injectors Market for Cardiovascular Disease
7.4.1 Global wearable injector market for cardiovascular disease, by region
7.5 Wearable Injectors Market for Blood Disorder
7.6 Global wearable injector for blood disorder, by region
8. Global Wearable Injectors Market, by End User
8.1 Wearable Injector Market in Homecare
8.2 Global wearable injector market in homecare, by region
8.3 Wearable Injector Market in Hospital
8.4 Global wearable injector market in hospital, by region
8.5 Wearable Injector Market in Lab & Diagnostics
8.6 Global wearable injector market in lab & diagnostics, by region
9. Global Wearable Injectors Market, by Geography
9.1 North America Wearable Injector Market
9.2 Latin America Wearable Injector Market
9.3 Europe Wearable Injector Market
9.4 APAC Wearable Injector Market
9.5 MEA Wearable Injector Market
10. Competitive Landscape
10.1 Porters Five Forces of Competitive Position Analysis
10.1.1 Bargaining power of buyers
10.1.2 Bargaining power of suppliers
10.1.3 Threat of new entrants
10.1.4 Intensity of rivalry
10.1.5 Threat of substitutes
10.2 Competitive Positioning of the Global Wearable Injectors Market, by Type
10.3 Competitive Benchmarking Of the Key Players in the Global Wearable Injectors Market, by Type
10.4 Market Share Analysis of the Global Wearable Injectors Market
10.5 Key Company Profiles
10.5.1 Becton, Dickinson and Company
10.5.2 Medtronic plc
10.5.3 Johnson & Johnson
10.5.4 F. Hoffmann-La Roche Ltd.
10.5.5 Unilife Corporation
10.5.6 CeQur SA
10.5.7 Sensile Medical AG
10.5.8 Enable Injections
10.5.9 ScPharmaceuticals, Inc.
10.5.10 SteadyMed Ltd.
10.5.11 Insulet Corporation
10.5.12 Ypsomed Group
10.5.13 West Pharmaceutical Services, Inc.
10.5.14 Bhler Motor GmbH
10.5.15 Can S.p.A.
10.6 Strategic Developments in the Global Wearable Injectors Market
10.7 List of Abbreviations
For more information about this report visit https://www.researchandmarkets.com/research/mv9vgv/wearable?w=12
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infusions and Injectables , Wearable Technology, Needles and Syringes
